Pharmacological basis for the potential role of Azithromycin and Doxycycline in management of COVID-19
A novel corona virus SARS-CoV-2 has led to an outbreak of the highly infectious pandemic COVID-19 complicated viral pneumonia. Patients with risk factors frequently develop secondary infections where the role of appropriate antibiotics is mandatory. However, the efforts of drug repurposing lead to r...
Main Authors: | Ahmed S. Ali, Mai A. ASattar, Shahid Karim, Dina Kutbi, Hanin Aljohani, Duaa Bakhshwin, Mohammed Alsieni, Huda M. Alkreathy |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | Arabian Journal of Chemistry |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S187853522030544X |
Similar Items
-
Comparison of therapeutic effects of topical azithromycin versus topical azithromycin with systemic doxycycline on posterior blepharitis
by: Mohamed A. H Ibrahim, et al.
Published: (2023-01-01) -
Azithromycin Versus Co-trimoxazole in The Treatment of Doxycycline Resistant Acne Vulgaris In Iraqi Patients
by: Basman M. Fadheel
Published: (2013-04-01) -
Azithromycin versus doxycycline for the treatment of urogenital Chlamydia trachomatis infection—a retrospective study
by: Ligang YANG, et al.
Published: (2021-06-01) -
COMPARISON OF MONTHLY PULSE OF ORAL AZITHROMYCIN WITH DAILY DOXYCYCLINE IN THE TREATMENT OF MODERATE ACNE VULGARIS
by: Muhammad Mudassir, et al.
Published: (2021-01-01) -
Oral azithromycin and oral doxycycline for the treatment of Meibomian gland dysfunction: A 9-month comparative case series
by: Giacomo De Benedetti, et al.
Published: (2019-01-01)